| 0 (0%) | 02-21 18:46 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.03 |
1-year : | 2.24 |
| Resists | First : | 1.74 |
Second : | 1.91 |
| Pivot price | 1.59  |
|||
| Supports | First : | 1.46 |
Second : | 1.21 |
| MAs | MA(5) : | 1.53 |
MA(20) : | 1.65 |
| MA(100) : | 1.44 |
MA(250) : | 1.4 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 21.7 |
D(3) : | 24.2 |
| RSI | RSI(14): 42.3 |
|||
| 52-week | High : | 1.96 | Low : | 1.12 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ MNOV ] has closed above bottom band by 8.2%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.59 - 1.6 | 1.6 - 1.61 |
| Low: | 1.44 - 1.46 | 1.46 - 1.47 |
| Close: | 1.48 - 1.5 | 1.5 - 1.52 |
Fri, 20 Feb 2026
MediciNova: Q4 Earnings Snapshot - Stamford Advocate
Fri, 20 Feb 2026
MediciNova (NASDAQ:MNOV) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Fri, 20 Feb 2026
MediciNova reports preliminary 2025 financial results in Tokyo filing - Investing.com
Mon, 16 Feb 2026
MediciNova, Inc. (NASDAQ:MNOV) Short Interest Update - MarketBeat
Sun, 15 Feb 2026
MediciNova Projected to Post Earnings on Wednesday - National Today
Wed, 04 Feb 2026
MediciNova (MNOV) Price Target Increased by 28.57% to 9.18 - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 4.209e+007 (%) |
| Held by Institutions | 2.8 (%) |
| Shares Short | 283 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.335e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 741.6 % |
| Return on Equity (ttm) | -15.9 % |
| Qtrly Rev. Growth | 257920 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -47.57 |
| EBITDA (p.s.) | 51568.6 |
| Qtrly Earnings Growth | -0.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.04 |
| Price to Cash Flow | 0.85 |
| Dividend | 0 |
| Forward Dividend | 270700 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|